Moderator:
- Ethan Lenz, Partner, Foley & Lardner LLP
Panelists:
- David Bradford, Co-Founder and Executive Vice President, Advisen, Ltd., and Editor-in-Chief, RIMS Benchmark Survey
- Dan Kugler, Corporate Risk Manager, Snap-On, Inc. and Board Member, RIMS
- Dan Fortin, Senior Vice President, CNA Specialty Lines
Topics included:
- Claims that have arisen from the crisis
- New claims that may be on their way
- Financial impact of crisis-related claims on an insurer’s bottom line
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.